
Natura &Co Holding S.A. Financial Ratios 2023-2011 | NTCO
Brief overview of Natura &Co Holding S.A.'s multiples and efficiency
Ratios are assessed across five available annual reports in the 2019–2023 interval.
The valuation comparison uses P/E 3.04x (median 12.27x), EV/EBITDA 72.47x (median 38.25x), P/S 0.34x (median 0.34x). On average, multiples differ from their five-year medians by only 0%. Valuation is near its familiar historical range.
The inverse P/E implies an earnings yield of 32.9%. This is not a dividend yield, but current earnings relative to market price.
End-period return metrics are ROE 12.9%, ROA 7%, ROCE -0.5%. The business is not generating positive returns on invested resources. Valuation should be read cautiously until earnings recover.
Conclusion
Natura &Co Holding S.A.'s multiples form a balanced picture without a clear discount or premium. Future appeal depends on earnings and return trends.
Annual Financial Ratios Natura &Co Holding S.A.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
3.0 | -3.1 | 12.3 | -37.5 | 17.8 | - | - | - | - | - | - | - | - |
P/S |
0.3 | 0.3 | 0.4 | 0.7 | 0.2 | - | - | - | - | - | - | - | - |
EPS |
2.2 | -2.1 | 0.8 | -0.5 | 0.2 | 0.6 | 1.6 | - | - | - | - | - | - |
EV (Enterprise Value) |
24.9 B | 37.1 B | 40.6 B | 52.6 B | 13.3 B | 11.6 B | -1.69 B | - | - | - | - | - | - |
EBITDA per Share |
-0.11 | -0.28 | 0.41 | 0.63 | 1.56 | 1.45 | 1.57 | - | - | - | - | - | - |
EV/EBITDA |
-161.0 | -96.8 | 72.5 | 66.6 | 9.8 | 9.2 | -1.2 | - | - | - | - | - | - |
PEG |
-0.05 | 0.06 | - | 0.13 | -4.99 | - | - | - | - | - | - | - | - |
P/B |
0.4 | 0.4 | 0.4 | 0.9 | 0.8 | - | - | - | - | - | - | - | - |
P/CF |
-3.9 | 13.4 | -111.8 | 19.4 | 2.1 | - | - | - | - | - | - | - | - |
ROE % |
12.87 | -12.79 | 3.64 | -2.42 | 4.62 | 21.30 | 41.00 | - | - | - | - | - | - |
ROA % |
6.96 | -5.23 | 1.72 | -1.09 | 0.73 | 3.57 | - | - | - | - | - | - | - |
ROCE % |
-0.48 | -0.93 | 1.20 | 1.76 | 9.89 | 11.62 | 83.11 | - | - | - | - | - | - |
Current Ratio |
2.2 | 1.7 | 1.9 | 1.8 | 1.2 | 1.2 | - | - | - | - | - | - | - |
All numbers in BRL currency
Quarterly Financial Ratios Natura &Co Holding S.A.
| 2023-Q4 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
2.1582 | -2.0843 | - | - | - | 0.761 | - | - | - | -0.522 | - | -0.3211 | - | 0.1796 | - | 0.0649 | - | 0.6335 | - | - | - | 1.5574 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.11 | -0.28 | - | - | - | 0.41 | - | - | - | 0.63 | - | - | - | 1.56 | - | - | - | 1.45 | - | - | - | 1.57 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
1.30 | -13.25 | -0.46 | -0.46 | -0.46 | 4.16 | 0.52 | 0.52 | 0.52 | 2.59 | 5.01 | 26.31 | 28.00 | 69.00 | 64.38 | 2.07 | - | 21.30 | - | - | - | 41.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
2.36 | -5.24 | -0.01 | -0.01 | -0.01 | 0.72 | -1.00 | -1.00 | -1.00 | 2.57 | 3.66 | -0.64 | - | 0.73 | - | - | - | 3.57 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
1.55 | 1.93 | 2.85 | 2.85 | 2.85 | 12.74 | 11.54 | 11.54 | 11.54 | 22.11 | 20.34 | 31.96 | 32.07 | 115.18 | 105.30 | 10.56 | - | 11.62 | - | - | - | 83.11 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
2.2 | 1.7 | - | - | - | 1.9 | - | - | - | 1.8 | - | 1.6 | - | 1.2 | - | - | - | 1.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in BRL currency
Multiples are an important financial analysis tool for the company Natura &Co Holding S.A., allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Household products industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Spectrum Brands Holdings
SPB
|
$ 88.81 | 1.58 % | $ 2.28 B | ||
|
United-Guardian
UG
|
$ 7.62 | -1.8 % | $ 35 M | ||
|
Unilever PLC
UL
|
$ 60.94 | 1.21 % | $ 133 B | ||
|
Acme United Corporation
ACU
|
$ 53.94 | 3.97 % | $ 204 M | ||
|
Dogness (International) Corporation
DOGZ
|
$ 0.95 | -0.05 % | $ 12.7 M | ||
|
Revlon
REV
|
- | -4.41 % | $ 212 M | ||
|
e.l.f. Beauty
ELF
|
$ 77.36 | 1.59 % | $ 4.24 B | ||
|
Coty
COTY
|
$ 2.65 | 1.73 % | $ 2.31 B | ||
|
Hims & Hers Health
HIMS
|
$ 28.09 | -14.2 % | $ 6.32 B | ||
|
Helen of Troy Limited
HELE
|
$ 28.47 | 6.07 % | $ 655 M | ||
|
Edgewell Personal Care Company
EPC
|
$ 27.63 | 3.52 % | $ 1.31 B | ||
|
The Clorox Company
CLX
|
$ 95.55 | 1.87 % | $ 11.8 B | ||
|
Church & Dwight Co.
CHD
|
$ 97.64 | 1.52 % | $ 23.7 B | ||
|
Newell Brands
NWL
|
$ 5.08 | 0.99 % | $ 2.12 B | ||
|
Kimberly-Clark Corporation
KMB
|
$ 109.7 | 2.23 % | $ 36.4 B | ||
|
Nature's Sunshine Products
NATR
|
$ 20.4 | -0.58 % | $ 367 M | ||
|
Nu Skin Enterprises
NUS
|
$ 5.08 | - | $ 250 M | ||
|
LifeVantage Corporation
LFVN
|
$ 6.53 | 4.15 % | $ 80 M | ||
|
The Estée Lauder Companies
EL
|
$ 80.29 | 0.46 % | $ 28.9 B | ||
|
USANA Health Sciences
USNA
|
$ 21.32 | 1.91 % | $ 395 M | ||
|
The Procter & Gamble Company
PG
|
$ 147.41 | 1.1 % | $ 346 B | ||
|
Mannatech, Incorporated
MTEX
|
$ 4.5 | -3.43 % | $ 8.55 M | ||
|
Colgate-Palmolive Company
CL
|
$ 90.75 | 0.74 % | $ 73.4 B | ||
|
Inter Parfums
IPAR
|
$ 122.55 | 2.34 % | $ 3.93 B |